Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vascular endothelial growth factor-2 gene therapy - Corautus Genetics

Drug Profile

Vascular endothelial growth factor-2 gene therapy - Corautus Genetics

Alternative Names: VEGF-2 gene therapy - Corautus Genetics

Latest Information Update: 11 Jun 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Human Genome Sciences
  • Developer Boston Scientific Corporation
  • Class Cytokine genes; Gene therapies; Growth factors
  • Mechanism of Action Angiogenesis inducing agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Suspended Angina pectoris; Coronary artery restenosis; Diabetic neuropathies; Ischaemic heart disorders; Vascular disorders

Most Recent Events

  • 06 Jun 2007 Corautus Genetics has been acquired and merged into VIA Pharmaceuticals
  • 03 Nov 2006 Suspended - Phase-I for Diabetic neuropathies in USA (Parenteral)
  • 03 Nov 2006 Suspended - Phase-II for Angina pectoris in USA (Intracoronary)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top